The reduction of ACE2 generates an imbalance in the RAS system: on one side an increased level of circulating Ang II, on the other a decreased signaling by the ACE2-derived peptides (Ang 1-7) resulting in hypertension, inflammation and lung damage (Figure 2) (61). This evidence concerns the gene ACE2 and hypertensive disorder.